DNLI
NASDAQ HealthcareDenali Therapeutics Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $20.70 |
|---|---|
| Volume | 1,329,582 |
| Market Cap | 3.28B |
| Beta | 1.080 |
| RSI (14-Day) | 53.1 |
| 200-Day MA | $16.46 |
| 50-Day MA | $19.70 |
| 52-Week High | $23.77 |
| 52-Week Low | $10.57 |
| Forward P/E | -8.37 |
| Price / Book | 3.19 |
🎯 Investment Strategy Scores
How DNLI scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
23/100
High dividend yield + low volatility
🚀 Moon Shot
40/100
High growth potential (high beta + oversold)
🔪 Falling Knife
14/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
77/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
51/100
Large-cap, institutional-quality stocks
Find DNLI in your text
Paste any text on the homepage — the tool will extract DNLI and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.